Navigation Links
Global nitrogen availability consistent for past 500 years, linked to carbon levels
Date:3/21/2013

that there is no net effect on the biosphere."

The balance may be only temporary, McLauchlan said.

"Based on what we learned from the past, if the response of plants to elevated carbon dioxide slows, nitrogen availability is likely to increase and ecosystems will begin to change profoundly," McLauchlan said. "Now more than ever, it's important to begin monitoring our grasslands and forests for early warning signs."


'/>"/>

Contact: Kendra McLauchlan
mclauch@k-state.edu
785-532-6155
Kansas State University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Novo Nordisk and BGI establish global collaboration framework
2. EU-funded study underlines importance of Congo Basin for global climate and biodiversity
3. Global warming threat to coral reefs: Can some species adapt?
4. 1 solution to global overfishing found
5. Young researcher taking fight against global killer to the next level in Vietnam
6. Heightened Security Threats and Economic Issues Provide Fillip to Global Civil and Military Biometrics Market, Says Frost & Sullivan
7. Global Information Inc. Announces Discounted Conference Registration For Bio-IT World Asia and Biodetection Technologies 2012
8. Global effort launched to save turtles from extinction
9. New Biotech and Pharmaceutical Market Research from Global Information Inc Forecasts Strong Growth Coming Out of Recession
10. 2012 Forecast for US Molecular Diagnostics Market Now Available From Global Information Inc.
11. Desert to Rainforest global classroom links future teachers, classrooms in Phoenix and Panama
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/14/2015)... NEW YORK , May 14, 2015 ... specializing in identity verification and online remote ... Instructure, a software-as-a-service (SaaS) company and creator ... Shared customers of the two companies will ... Proctortrack in Canvas. As a ...
(Date:5/11/2015)... 11, 2015 Curemark LLC, a privately held ... a new Phase III double blind, randomized, placebo-controlled clinical ... CM-AT, on all children ages 3-8 with Autism. Previously, ... III double blinded clinical trial for CM-AT in children ... the digestive enzyme chymotrypsin. This new trial will help ...
(Date:5/7/2015)... GOTHENBURG, Sweden , May 7, 2015 /PRNewswire/ ... new touch fingerprint sensors, FPC1022 and FPC1035, FPC,s ... FPC1022 and FPC1035 are mainly considered for integration ... decreased size gives smartphone OEMs increased possibilities to ... portfolio. The decreased size also improves possibilities for ...
Breaking Biology News(10 mins):Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2
... Venus Express has detected the molecule hydroxyl on another ... an important new tool to unlock the workings of ... molecule, is made up of a hydrogen and oxygen ... reaches of the Venusian atmosphere, some 100 km above ...
... to stave off the cognitive deficits that occur with ... published in the second issue for May of the ... Care Medicine. Researchers examined the effects green tea ... were intermittently deprived of oxygen during 12-hour night cycles, ...
... the Great Lakes with things like trout and salmon would be ... the water, so it would be natural to assume that more ... in the April journal of Ecology by the Ecological Society of ... and trout to the area has not been good for the ...
Cached Biology News:Key molecule discovered in Venus's atmosphere 2Green tea compounds beat OSA-related brain deficits 2Restoring fish populations leads to tough choice for Great Lakes Gulls 2
(Date:6/1/2015)... , June 1, 2015 GenomeDx ... genomic analysis platform, successfully classified various subtypes ... expression of certain biomarkers, including one type ... this unique genomic signature has potential as ... neoadjuvant chemotherapy in patients with muscle-invasive bladder ...
(Date:6/1/2015)... 2015  Novartis is highlighting data from an ... investigational chimeric antigen receptor (CAR) T cell therapy, ... specific types of hard-to-treat non-Hodgkin lymphoma. Findings from ... Pennsylvania,s Perelman School of Medicine (Penn) in adults ... lymphoma (DLBCL) and follicular lymphoma (FL) found an ...
(Date:6/1/2015)... Grove, IL (PRWEB) June 01, 2015 ... in developing and manufacturing of chiral stationary phases ... the options for its current and presenting solutions ... Service to its portfolio. This valuable addition to ... fast and effective advantage that can tackle projects ...
(Date:6/1/2015)...  Boston-based Veritas Genetics is launching its mission ... personalized medicine and prevention to the forefront, allowing ... Beginning with its first product, a genetic screen ... Genetics is making its products affordable and accessible, ... genetic data which will be shared with the ...
Breaking Biology Technology:GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 4Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 2Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 3Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 4Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 5Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 6Regis Technologies Offers Chiral Chromatography Service 2Regis Technologies Offers Chiral Chromatography Service 3Veritas Genetics To Advance Precision Medicine And Disease Prevention 2Veritas Genetics To Advance Precision Medicine And Disease Prevention 3
... ... Spectrum Software announces key hire. Cindy Larkin has been hired as Director of ... her new role. , ... Southborough, MA (Vocus) November 3, 2009 -- Leading medical device and life sciences ...
... 2 BioBehavioral Diagnostics Company announced today that its ... was accepted via a rigorous peer-review process and included ... Meeting of the American Academy of Child and Adolescent ... Calvin R. Sumner, M.D., the company,s Chief Medical Officer ...
... 2 Microfluidics International Corporation (OTC Bulletin Board: MFLU), ... ended September 30, 2009. , (Logo: ... accomplishments: , Earned net income for the ... before interest, taxes, depreciation and amortization (EBITDA) Delivered ...
Cached Biology Technology:Medical Device Software Engineering Firm Full Spectrum Software Appoints Cindy Larkin to Director of Client Services 2Objective Measures of ADHD Symptoms Using the Quotient(TM) ADHD System May Reduce Cost of ADHD Drug Trials 2Objective Measures of ADHD Symptoms Using the Quotient(TM) ADHD System May Reduce Cost of ADHD Drug Trials 3Objective Measures of ADHD Symptoms Using the Quotient(TM) ADHD System May Reduce Cost of ADHD Drug Trials 4Microfluidics International Corporation Announces Third Quarter 2009 Financial Results 2Microfluidics International Corporation Announces Third Quarter 2009 Financial Results 3Microfluidics International Corporation Announces Third Quarter 2009 Financial Results 4Microfluidics International Corporation Announces Third Quarter 2009 Financial Results 5Microfluidics International Corporation Announces Third Quarter 2009 Financial Results 6Microfluidics International Corporation Announces Third Quarter 2009 Financial Results 7Microfluidics International Corporation Announces Third Quarter 2009 Financial Results 8Microfluidics International Corporation Announces Third Quarter 2009 Financial Results 9
Maxi 14 Hybridization Oven. 14 bottle (35 mm) rotisserie + shaker tray available for simultaneous use. Includes linear and orbital shaker trays, 4 medium bottles, pack of mesh, bottle gripper and d...
Shake 'n' Stack Oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual PLUS Shaker Platform)...
... The Neural Stem Cell Expansion Kit - ... in vitro NSC expansion as a monolayer ... specially formulated N-2 Plus Media Supplement, which has ... K.K. et al . (1996) Genes & ...
... is a preparation of deoxyribonuclease I ... to produce 3-hydroxyl oligonucleotides. This preparation ... where maintaining the integrity of RNA ... for use with the Core Footprinting ...
Biology Products: